Department of Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong.
Hong Kong Med J. 2013 Feb;19(1):77-9.
Non-cirrhotic portal hypertension is an unusual but potentially serious liver disorder in human immunodeficiency virus-infected patients with prolonged exposure to didanosine. Due to its rarity, the diagnosis is often delayed. It is postulated that didanosine contributes to obliterative portal venopathy and causes portal hypertension. Affected patients may present with abnormal liver function or signs of portal hypertension, while the diagnosis usually depends on liver biopsy. We report a case of non-cirrhotic portal hypertension in a human immunodeficiency virus-infected patient. The reported histological features include nodular regenerative hyperplasia and hepatoportal sclerosis. Early recognition is important as timely management of severe portal hypertension may prevent potentially fatal gastro-intestinal bleeding.
非肝硬化性门静脉高压症是人类免疫缺陷病毒感染患者中一种不常见但潜在严重的肝脏疾病,这些患者长期暴露于双脱氧肌苷。由于其罕见性,诊断常常被延误。据推测,双脱氧肌苷可导致闭塞性门静脉病并引起门静脉高压症。受影响的患者可能表现出肝功能异常或门静脉高压的迹象,而诊断通常依赖于肝活检。我们报告了一例人类免疫缺陷病毒感染患者的非肝硬化性门静脉高压症。报道的组织学特征包括结节性再生性增生和肝门静脉硬化。早期识别很重要,因为及时治疗严重的门静脉高压症可预防潜在致命的胃肠道出血。